Find Academic Supervisors

Tamar Schlick is a Professor at New York University, affiliated with the Courant Institute of Mathematical Sciences and the Department of Chemistry. She holds roles as an Associate (Lead) Editor for the International Journal for Multiscale Computational Engineering and has contributed to numerous journals. Education: B.S. in Mathematics, Wayne State University (1982) M.S. and Ph.D. in Applied Mathematics, Courant Institute of Mathematical Sciences, NYU (1984 and 1987) Research Interests: Tamar Schlick focuses on biomolecular modeling, chromatin dynamics, RNA structure prediction, and computational methods for understanding biological systems. Her work integrates computational simulations with experimental data to study complex systems like DNA repair mechanisms, histone interactions, and RNA folding pathways. Her research bridges disciplines such as biophysics, biochemistry, and applied mathematics. Articles Trends: Her recent publications emphasize multiscale modeling in chromatin organization, RNA structural prediction using graph theory, and energy landscapes in biomolecular interactions. These studies highlight advancements in computational tools and their applications in understanding fundamental biological processes. Awards: Over 20 awards, including the John Simon Guggenheim Fellowship (2000-2001), American Physical Society Fellow (2005), and Aspen Health Forum Fellow (2007). Recognitions for contributions to computational chemistry, RNA science, and biomolecular modeling. Advising & Grants: While specific student advisees are not listed, her research groups collaborate on projects funded by NIH, NSF, and other agencies. She leads teams advancing computational frameworks like RAGTOP and CHSalign for RNA structure analysis. Labs/Teams: Active in NYU’s Courant Institute and NYU-ECNU Center for Computational Chemistry, focusing on interdisciplinary research in computational biophysics and molecular modeling.

• Computational Chemistry
• Structural Biology
• Biophysics
• +3 more

Magnus Lundgren serves as Director of the SciLifeLab Ancient DNA facility at Uppsala University's Department of Organismal Biology, where he holds the academic rank of Docent (Associate Professor). His role involves providing ancient DNA analysis services to researchers globally, bridging historical inquiry with molecular techniques to explore human evolution and ecological changes. Lundgren's research spans microbiology, biotechnology, and ancient DNA analysis. Initially focused on thermophilic microorganisms and CRISPR-Cas systems in archaea, his work evolved toward developing ancient DNA methodologies. Current projects analyze historical societies through genetic evidence, resolving kinship questions and tracing ecological shifts over time. His dual expertise in microbial genetics and historical genomics enables innovative cross-disciplinary applications. Publication trends reveal a strategic shift from fundamental archaeal cell cycle studies (2004-2010) to applied ancient DNA work (2017-2023), with CRISPR technology serving as a consistent thread. Early papers in Cell and PNAS established his expertise in DNA replication, while recent work applies these principles to archaeological samples and historical kinship resolution. No scientific awards were explicitly mentioned in the source text. Through the SciLifeLab facility, Lundgren mentors researchers and supports collaborative projects across Sweden and internationally. The facility provides critical infrastructure for ancient DNA studies, though specific grant details weren't provided. His leadership enables diverse research in evolutionary biology and archaeology. The SciLifeLab Ancient DNA facility operates as a national resource under Lundgren's direction, offering specialized analysis services for archaeological and historical samples. This infrastructure supports interdisciplinary teams studying human migration patterns, historical epidemics, and ecological adaptations through time-resolved genetic data.

• Microbiology
• Ancient DNA
• CRISPR Technology
• +3 more

Virginia Panara is a Research Fellow in the Department of Organismal Biology at Uppsala University, Sweden, affiliated with the Evolutionary Biology Centre (EBC). Her research focuses on molecular mechanisms of lymphatic vascular development using zebrafish models, with emphasis on gene regulatory networks and evolutionary perspectives. She maintains an active publication record in high-impact journals including Nature and Development. Her primary research interests encompass developmental biology, lymphatic system regulation, evolutionary developmental biology (Evo-Devo), molecular genetics of endothelial cell specification, and zebrafish modeling. She employs advanced methodologies such as confocal microscopy, single-cell RNA sequencing, and computational image analysis to investigate transcriptional control mechanisms involving genes like prox1a and Dmrt , particularly examining cis-regulatory elements and cell migration dynamics in vascular patterning. Analysis of her 2018-2025 publications reveals a cohesive research trajectory centered on lymphatic endothelial cell identity, with increasing methodological sophistication from phylogenetic studies to multi-omic approaches. Key themes include the relationship between lymphatic and secondary vascular systems in fish, epigenetic regulation of cell lineages, and topographically distinct genetic control of vessel formation, demonstrating interdisciplinary integration of developmental, evolutionary, and systems biology perspectives. No scientific awards are documented in the available information. There is no available data regarding her advisory roles, graduate students, or research grant funding. Dr. Panara collaborates with multiple research groups at Uppsala University, including teams led by Katarzyna Koltowska (vascular development) and Ralf Janssen (evolutionary biology), contributing to a dynamic research environment focused on uncovering molecular principles of endothelial cell identity through the Evolutionary Biology Centre's infrastructure.

• Developmental Biology
• Lymphatic System Research
• Evolutionary Developmental Biology
• +2 more

Dr. Mary Scott is a Research Fellow at the Paul O'Gorman Leukaemia Research Centre within the Wolfson Wohl Cancer Research Centre at the University of Glasgow, focusing on chronic myeloid leukemia (CML) stem cell biology and therapeutic resistance mechanisms. Her research centers on: Metabolic vulnerabilities in leukemic stem cells (arginine dependency, pyruvate anaplerosis) Epigenetic reprogramming and EZH2 inhibition strategies p53-mediated self-renewal pathways in residual CML disease Microenvironment interactions in the bone marrow niche Recent publications reveal a strong trend toward targeting persistent leukemic stem cells through dual metabolic-epigenetic approaches, with increasing emphasis on mitochondrial metabolism and transcriptional reprogramming as therapeutic avenues. Dr. Scott's research is supported by active grants: 2024-2025: Identification of biomarkers predictive of TKI response in CML (Tenovus Scotland) 2023-2026: Functional analysis of leukemia stem cell subtypes in CML (Leukaemia UK) 2014-2017: H3K27 methylation modulation for eradicating TKI-persistent CML stem cells (Blood Cancer UK) She operates within the Paul O'Gorman Leukaemia Research Centre team, utilizing advanced molecular profiling techniques to investigate therapy-resistant CML populations and develop novel eradication strategies.

• Chronic Myeloid Leukemia
• Leukemic Stem Cell Biology
• Cancer Metabolism
• +3 more

Dr. Musa Marimani is a Lecturer in the Department of Anatomical Pathology at the University of the Witwatersrand Medical School, Johannesburg, South Africa. He holds a PhD from the same institution. His research focuses on epigenetic mechanisms underlying HIV and tuberculosis (TB) co-infection, particularly how viral and bacterial pathogens disrupt host immunity through epigenetic modifications like methylation, phosphorylation, and acetylation. He explores these mechanisms to develop diagnostic biomarkers and novel therapies. His work also addresses antimicrobial resistance, drug delivery systems, and natural product-based therapeutics. Education : BSc (University of the Witwatersrand) BSc Honours (University of the Witwatersrand) MSc (University of the Witwatersrand) PhD (University of the Witwatersrand) Research Interests : Gene therapy, RNA interference, molecular medicine, and microbiology, with emphasis on HIV-TB co-infection, epigenetic regulation, and antimicrobial resistance. His projects aim to identify therapeutic targets and biomarkers for improved diagnostics and treatment regimens. Publications : His recent work includes studies on epigenetic regulation in co-infected patients, nanoemulsion drug carriers for multi-drug resistance, and natural products against pathogens like Candida auris and Listeria monocytogenes . A notable focus is on host-pathogen interactions and the development of novel therapies to combat drug-resistant infections. Grants/Advising : No specific grants or student advising roles are detailed in the provided information. Labs/Teams : Research conducted within the University of the Witwatersrand’s Medical School, collaborating on interdisciplinary projects in molecular pathology and infectious diseases.

• Gene Therapy
• RNA Interference
• Molecular Biology
• +7 more

Peter Beal is a Professor in the Chemical Biology Program at the University of California, Davis. His research focuses on using synthetic chemistry to study RNA structure, function, and therapeutic applications. Key areas include RNA editing by ADAR enzymes and RNA interference via siRNA modifications. He leads the Beal Lab and collaborates extensively with structural biologists like Andrew Fisher. Appointed UC Davis faculty in 2006 NIH T32 Training Grant Program Director (2015) Fellow of the American Association for the Advancement of Science (2012) Research interests: - Designing nucleoside analogs to interrogate RNA biology - Developing siRNA-based therapeutics with reduced immunogenicity - Elucidating ADAR2's mechanism and site selectivity through structural studies - Creating tools to modulate RNA editing in living cells His NIH-funded projects investigate RNA editing's role in disease and siRNA optimization for clinical use. Recent work includes fluorescent adenosine analogs for real-time editing monitoring and computational screening of siRNA modifiers. Scientific awards: Camille Dreyfus Teacher Scholar (2000), Robert Parry Teaching Award (2005) Grants: Active NIH grants for RNA editing studies and siRNA development. Collaborates with industry on therapeutic siRNA candidates. Labs/Teams: Beal Lab focuses on chemical biology approaches to RNA biology. Active in the UC Davis Chemical Biology Program.

• Chemical Biology
• RNA Editing
• RNA Interference
• +3 more

Professor Espen Rimstad is a leading virologist at the Norwegian University of Life Sciences (NMBU), affiliated with the School of Veterinary Science and the Virology Department. He leads a research group of 10–12 scientists focused on viral infections in fish, particularly in aquaculture species such as Atlantic salmon and rainbow trout. His research interests include: Viral diseases in fish (e.g., pancreas disease, cardiomyopathy syndrome, HSMI) Vaccinology, including plant-made and mRNA-based vaccines Pathogenesis of piscine orthoreovirus (PRV), salmonid alphavirus (SAV), and infectious salmon anaemia virus (ISAV) Fish immunology and host-pathogen interactions Emerging viral threats in aquaculture His recent publications reflect a strong trend in developing novel vaccine platforms, understanding immune responses in fish, and characterizing viral pathogenesis using advanced molecular and transcriptomic techniques. Many of his studies focus on improving fish health and aquaculture sustainability through science-based solutions. Scientific contributions include: Over 329 publications with high citation impact Leadership in national risk assessments (e.g., VKM) Development of inactivated and live attenuated vaccines Pioneering work on mRNA-LNP delivery in fish He has advised numerous students and researchers, though specific names are not listed. His work is supported by major research projects such as ViVaFish (Fish Virus Vaccines). He collaborates extensively with institutions like the Norwegian Veterinary Institute and international partners. He is also involved in ethical and environmental assessments related to aquaculture practices. Rimstad is active in multiple laboratories and research networks, contributing to both fundamental and applied aspects of fish virology. His lab at NMBU is a hub for innovation in aquatic animal health, with ongoing work on viral diagnostics, vaccine development, and disease mitigation strategies.

• Virology
• Fish Diseases
• Aquaculture Health
• +7 more

Filip J. Bihelovic is an Associate Professor at the Department of Organic Chemistry , Faculty of Chemistry , University of Belgrade. He holds a Ph.D. in Chemistry from the same institution (2011) and has been employed there since 2006, progressing through roles including Teaching Assistant (2006-2008), Assistant (2008-2014), and Assistant Professor (2014-2019). His research focuses on total synthesis , organometallic chemistry , asymmetric organocatalysis , and medicinal chemistry , with notable contributions to anti-viral drug development (e.g., SARS-CoV-2 inhibitors) and natural product synthesis. Education History: B.Sc. Chemistry (2005), Faculty of Chemistry, University of Belgrade Ph.D. Chemistry (2011), Faculty of Chemistry, University of Belgrade Research Interests: Development of novel synthetic methodologies for complex natural products Gold-catalyzed domino reactions and their applications Enzymatic synthesis and biocatalysis Anti-RNA virus therapies (e.g., iminosugar-based glycosidase inhibitors) His scientific work includes over 20 peer-reviewed articles in top journals like Angewandte Chemie International Edition and Journal of Medicinal Chemistry . Notable honors include the Thieme Chemistry Journals Award (2022) for outstanding contributions to synthetic organic chemistry. Grants and Projects (selected): SMART Repurposing (2020-2022): Anti-COVID-19 drug development via repurposing iminosugars New SMART Synthesis (2022-2025): Advanced synthetic methods for bioactive molecules Laboratory activities include leading the Organic Synthesis and Methodology Group at Faculty of Chemistry, focusing on sustainable organic reactions and drug discovery.

• Organic Chemistry
• Total Synthesis
• Organometallic Chemistry
• +3 more

Hasindu Malshan Gamaarachchi is a Lecturer in the School of Computer Science and Engineering at UNSW Sydney since 2023, and a visiting scientist at the Garvan Institute of Medical Research's Genomic Technologies Group. He completed his PhD in Computer Science and Engineering at UNSW Sydney (2020) and holds a BSc (Hons.) in Computer Engineering from the University of Peradeniya (2015). His research focuses on bioinformatics software and hardware systems for real-time nanopore sequencing analysis, embedded computing, and GPGPU/FPGA acceleration. Education: PhD in Computer Science and Engineering, UNSW Sydney (2020) BSc Engineering (Hons.) in Computer Engineering, University of Peradeniya (2015) Research Interests: Design and optimization of domain-specific systems for genomics, including nanopore sequencing analysis, algorithmic efficiency, and hardware-software co-design. Key applications include real-time data processing and embedded systems for bioinformatics. Grants & Awards: ARC Discovery Early Career Researcher Award (DECRA) 2023 (Sole CI) ARC Discovery Projects 2023 (CI with Sri Parameswaran) 2021: Outstanding PhD Thesis Award (ABACBS), Dean's Award (UNSW) 2020: Third place at ACM SRC Awards span academic excellence (e.g., IET-YPS 2016) to bioinformatics innovation. Collaborates with industry and institutions like Garvan for genomic technologies.

• Bioinformatics
• Genomics Data Processing
• Embedded Systems
• +3 more

Prof. Jeyaprakash Arulanandam (JP) holds dual academic positions as a Professor at the Ludwig-Maximilian-Universität München (LMU) and a Personal Chair of Structural Cell Biology at the University of Edinburgh . His ERC-funded lab is based at LMU’s Gene Center (since March 2023) and continues operations at the University of Edinburgh. He co-heads the Institute of Cell Biology at Edinburgh and leads the Wellcome Centre for Cell Biology. His research focuses on the structural mechanisms of chromosome segregation during cell division, integrating cryoEM, crystallography, and proteomics. Key interests include centromere assembly, RNA modifications, and spindle dynamics. ERC funding supports his work on centromere inheritance and mitotic regulation. Awards and grants are not explicitly listed here, but his ERC grant underscores significant recognition. He advises students across both institutions, though specific names are not provided. LMU Affiliation: Gene Center, Department of Biochemistry Edinburgh Affiliation: Institute of Cell Biology, Wellcome Centre Research Highlights: Recent work addresses PLK1-mediated phosphorylation cascades, Mis18 complex assembly, and Sgo1-CPC interactions. These studies bridge structural biology with dynamic cellular processes, employing cutting-edge imaging and biochemical techniques.

• Structural Biology
• Cell Biology
• Molecular Biology
• +4 more

Christopher J. Falzone is an Associate Research Professor in the Department of Chemistry at Johns Hopkins University, with a long-standing secondary affiliation at The Pennsylvania State University, where he has served as Lecturer and Assistant Director of the NMR Facility since 1992. His academic home is within the Krieger School of Arts and Sciences at Johns Hopkins, where his research focuses on structural and dynamic properties of metalloproteins using NMR spectroscopy. Education: A.B. in Chemistry, Washington University (St. Louis) Ph.D. in Chemistry, 1984, Clarkson University (Potsdam, NY) Post-Doctoral Associate, University of Akron Post-Doctoral Associate, The Pennsylvania State University Dr. Falzone's research lies at the intersection of biochemistry and biophysics, with a strong emphasis on understanding protein structure, dynamics, and function—particularly in hemoproteins such as hemoglobins, cytochromes, and photosystem components. His work frequently explores how heme binding, covalent modifications, and metal coordination influence protein conformation and activity. He employs advanced NMR techniques to probe molecular interactions, folding pathways, and dynamic behavior in solution. His studies span diverse systems including cyanobacterial globins, Escherichia coli enzymes, and iron-sulfur clusters in photosynthetic complexes. Analysis of his recent publications reveals a sustained focus on metalloprotein structure and mechanism. The articles consistently apply NMR to characterize heme proteins, enzyme dynamics, and protein-ligand interactions. Key themes include heme pocket architecture, covalent cross-linking, hexacoordination, and the structural basis of electron transfer in photosystems. His work bridges structural biology with functional biochemistry, contributing to fundamental understanding of protein behavior in both prokaryotic and model eukaryotic systems. Although no formal scientific awards are listed in the provided text, Dr. Falzone's extensive publication record in high-impact journals such as Biochemistry , Journal of Molecular Biology , and Nature Structural Biology reflects significant scholarly contributions. His collaborative work with Dr. Julio Lecomte has produced influential insights into protein dynamics and metalloprotein function. Dr. Falzone has played a vital role in academic mentoring and education. At Penn State, he has served as Chemistry Undergraduate Advising Coordinator and Co-op Coordinator since 1997, guiding student development and academic planning. While no formal advisees are listed, his leadership in advising suggests a strong commitment to student mentorship. His research has likely been supported by federal grants, particularly from NIH or NSF, given the nature of his instrumentation (NMR) and collaborative, hypothesis-driven projects. He is an active member of the Lecomte Research Group, a team dedicated to biomolecular NMR and the study of protein structure and dynamics. The group utilizes advanced spectroscopic methods to investigate folding, stability, and functional mechanisms in metalloproteins. Their work integrates biochemical, biophysical, and computational approaches to unravel complex biological questions at the molecular level.

• Structural Biology
• Biophysics
• Nuclear Magnetic Resonance (NMR) Spectroscopy
• +7 more

Ben Montpetit is an Adjunct Assistant Professor in the Department of Viticulture & Enology at the University of California at Davis, College of Agricultural and Environmental Sciences. His research focuses on the molecular mechanisms of mRNA export through nuclear pore complexes (NPCs) and its implications in cellular stress responses and human diseases. Ph.D., University of British Columbia Research Interests Montpetit’s work investigates how NPCs regulate mRNA export at cellular, molecular, and atomic levels. His lab employs cell biology , biochemistry , structural biology , and single-molecule imaging in Saccharomyces cerevisiae to elucidate transport mechanisms. Future directions include expanding studies to mammalian systems to link mRNA export defects to diseases like cancer and neurodegenerative disorders. Publication Trends Montpetit's articles span RNA biology , nuclear transport , and protein-RNA interactions , with a focus on DEAD-box ATPases, nucleoporins, and stress-regulated export pathways. His work bridges basic cell biology and clinical relevance , particularly in disease mechanisms. Lab Members The Montpetit Lab collaborates with a multidisciplinary team of undergraduates, graduate students, postdocs, and staff, leveraging yeast and mammalian models to advance mechanistic understanding of RNA transport and processing. Contact Email: benmontpetit@ucdavis.edu Office: Department of Viticulture & Enology, UC Davis Phone: 530-752-9355

• Molecular Biology
• Cell Biology
• RNA Biology
• +3 more

Trever Bivona, MD, PhD, is a Professor in the Department of Medicine and the Department of Cellular and Molecular Pharmacology at the University of California, San Francisco (UCSF) School of Medicine. He is a physician-scientist and cancer biologist whose research focuses on signal transduction, tumor evolution, and drug resistance in lung cancer. Dr. Bivona earned his MD and PhD in Cell and Molecular Biology from New York University School of Medicine, completed residency in Internal Medicine at Brigham and Women's Hospital/Harvard, and pursued postdoctoral training in Medical Oncology and Cancer Biology at Memorial Sloan Kettering Cancer Center. His research program investigates the molecular mechanisms of oncogenic signaling, particularly through receptor tyrosine kinases (EGFR, ALK) and RAS GTPase pathways. A key recent discovery involves the role of membraneless cytoplasmic biomolecular condensates in driving oncogenic signaling and resistance. His work aims to understand tumor initiation, evolution, and therapeutic resistance to improve cancer therapy and patient outcomes. His recent publications highlight trends in cancer resistance mechanisms, tumor evolution, biomolecular condensates, and rational combination therapies. These works appear in high-impact journals such as Nature , Cancer Discovery , and Cell , reflecting a strong focus on translational and mechanistic cancer biology. Dr. Bivona has received significant recognition, including: NIH Director’s New Innovator Award Elected Member, American Society for Clinical Investigation He is actively involved in major research initiatives as Principal Investigator of the NIH/NCI U54 Bay Area Drug Resistance and Sensitivity Center and as a Chan-Zuckerberg Biohub Senior Investigator. His work includes advising on therapeutic strategies and securing substantial NIH funding for projects on RAS signaling, NF-κB inhibition, polytherapy optimization, and resistance mechanisms. Dr. Bivona leads the Bivona Lab at UCSF, a research team dedicated to understanding the molecular basis of cancer signaling and resistance, with a strong emphasis on translating findings into clinical applications for lung cancer patients.

• Cancer Biology
• Signal Transduction
• Cancer Genetics
• +12 more

Chen Liu is the Anthony N. Brady Professor of Pathology and Chair of the Department of Pathology at Yale School of Medicine. He oversees pathology services at Yale New Haven Hospital and holds leadership roles in multiple interdisciplinary programs including the Liver Cancer Program and Cancer Biomedical Data Science. Education: MD from Tong Liao Medical College (1980), PhD in Pathology from University of Pennsylvania (1993), residency in Anatomical/Clinical Pathology at Medical College of Pennsylvania, and postdoctoral training at Scripps Clinic. Former roles include Vice Chair at University of Florida and joint Chair at Rutgers University. Research Focus: Immunotherapy for liver cancers, graft-versus-host disease pathogenesis, cancer epigenetics, and microbiome interactions in oncology. His work bridges basic science and clinical translation, with emphasis on leveraging immune mechanisms to improve cancer therapy. Article Trends: Recent publications span immunotherapy biomarker development, GVHD microenvironment dynamics, and microbiota-driven cancer treatment responses. Collaborates frequently with oncologists, immunologists, and computational biologists. Awards: Endowed professorship (Anthony N. Brady Chair). Grants/Labs: Directs the Chen Liu Lab and participates in the Yale Cancer Center. Active in translational research programs like the Molecular Medicine Initiative and Genomics Core.

• Immunotherapy
• Liver Cancer
• Graft-versus-Host Disease
• +7 more

Dr. Tracey A. Rouault is a Physician Scientist leading the Section on Human Iron Metabolism at the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH) in Bethesda, MD. Her research focuses on the molecular regulation of iron and iron-sulfur cluster metabolism in mammalian systems. Research Interests: Dr. Rouault’s lab investigates the roles of iron regulatory proteins (IRPs) and iron-sulfur cluster biogenesis in health and disease. Her work spans neurodegenerative disorders such as Parkinson’s disease and Friedreich ataxia, hematologic conditions including anemias and polycythemia, and familial renal cancers. The lab employs mouse models, cell culture, and patient-derived lines to dissect the mechanisms of iron homeostasis and mitochondrial function. Recent Research Trends: Analysis of her recent publications reveals a strong focus on the role of iron-sulfur clusters in metabolic reprogramming, immune cell function, and epigenetic regulation. Her work continues to uncover novel protein complexes and regulatory motifs involved in Fe-S cluster assembly and iron transport, with implications for understanding and treating rare genetic and metabolic diseases. Scientific Awards: No specific awards mentioned in the provided text. Advising and Grants: Dr. Rouault mentors post-doctoral and graduate fellows. Opportunities are available through the NIH Graduate Partnership Program with universities such as Johns Hopkins, University of Maryland, Oxford, and Cambridge. Her research is supported by the NIH intramural funding program, indicating ongoing grant support for her lab’s investigations into iron metabolism and related disorders. Labs and Teams: She leads the Section on Human Iron Metabolism within NICHD, conducting interdisciplinary research that bridges biochemistry, genetics, and physiology to understand fundamental aspects of iron biology and their clinical implications.

• Iron Metabolism
• Iron-Sulfur Cluster Biogenesis
• Neurodegenerative Diseases
• +7 more